28/07/20 Esperite N.V. announced that it expects to receive €35 million in funding CI
27/08/19 Esperite N.V. and Myrisoph Capital Conclude a Strategic Agreement on Cryo-Save’s Family Stem Cell Banking Business CI
30/06/19 Esperite N.V. Reports Earnings Results for the Half Year Ended June 30, 2018 CI
13/06/19 Esperite Resumes Takeover Talks With Polski Bank Komorek Business CI
04/06/19 Esperite NV Introduces Jouvene - Swiss Medicine Quintessence, the First Combined Offer of Stem Cell Long Term Storage and Highly Accurate Whle Genome Sequencing for Consumer Distribution CI
28/05/19 Polski Bank Komórek Macierzystych S.A. cancelled the acquisition of Cryo-Save Family Stem Cell Banking business from Esperite N.V.. CI
22/02/19 Polski Bank Komórek Macierzystych S.A. entered into a memorandum of understanding to acquire Cryo-Save Family Stem Cell Banking business from Esperite N.V. for €10 million. CI
29/11/18 The Cell-Factory BVBA announced that it expects to receive funding from Esperite N.V. CI
24/11/18 Esperite N.V. Reports Consolidated Earnings Results for the Year Ended December 31, 2017 CI
03/10/18 Go Life Healthcare Limited cancelled the acquisition of Cryo-Save South Africa Ltd., from Esperite N.V.. CI
13/09/18 Esperite N.V. with Cryosave Stores More Than A Million Samples in its New Designed Cryostorage Facility in Geneva CI
02/07/18 Go Life Healthcare Limited agreed to acquire Cryo-Save South Africa Ltd., from Esperite N.V. for ZAR 20 million. CI
12/06/18 Esperite N.V. announced that it expects to receive €5 million in funding from L1 Capital Pty Limited CI
Logo Esperite N.V.
Esperite N.V. is an investment company specialized in equity participations in companies operating in the health and biotechnology sectors.
Employees
133
Sector
-